Adverse Drug Event. An undesirable effect reasonably associated with use of a drug that may occur as part of the pharmacological action of the drug or may be unpredictable in its occurrence. Adverse Drug Event does not include all adverse events observed during use of a drug; only those adverse events for which there is some basis to believe there is a causal relationship between the drug and the occurrence of the adverse drug event.
BSAS. The Bureau of Substance Addiction Services within the Department of Public Health.
The notice shall include a statement of the deficiencies found, and the provision(s) of law and regulation relied upon, and shall specify a reasonable time, not more than 60 days after receipt of the notice, by which time the facility shall remedy or correct each deficiency cited in the notice; provided however, that in the case of a deficiency which, in the opinion of the Department, is not capable of correction within 60 days, the Department's statement of deficiencies shall prescribe the time within which such deficiency shall be corrected. A deficiency notice issued pursuant to 104 CMR 27.03(20)(d) shall also include notice of actions the Department may take in the event facility fails to remedy or correct a cited deficiency by the date specified in the written deficiency notice or fails to remedy or correct a cited deficiency by the date specified in a plan for correction, as accepted or modified by the Department, pursuant to 104 CMR 27.03(20)(e).
104 CMR, § 27.03